Projects funded by the NCN
CHIRAL RHENIUM AND RHODIUM COMPLEXES OF ANTICANCER AND ANTIBACTERIAL ACTIVITY: SYNTHESIS, ACTIVITY, AND PHYSICOCHEMICAL PROPERTIES
2022/47/B/NZ7/02765
Keywords:
antitumor compounds chiral drugs non-platinum anticancer agents non-platinum antibacterial agents rhenium complexes rhodium complexes antibacterial activity physicochemical properties asymmetric synthesis chiroptical spectroscopy NMR spectroscopy X-ray diffractometry quantum-chemical calculations
Descriptors:
- NZ7_014:
- ST4_011:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Narodowy Instytut Leków
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 13
Call: OPUS 24 - announced on 2022-07-15
Amount awarded: 2 672 074 PLN
Project start date (Y-m-d): 2023-09-01
Project end date (Y-m-d): 2027-08-31
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Tricarbonyl rhenium(I) complexes with 8-hydroxyquinolines: structural, chemical, antibacterial, and anticancer characteristicsAuthors:Krzysztof Łyczko, Anna Pogorzelska, Urszula Częścik, Mirosława, Koronkiewicz, Joanna E. Rode, Elżbieta Bednarek, Robert Kawęcki, Karolina Węgrzyńska, Anna Baraniak, Małgorzata Milczarek, Jan Cz. DobrowolskiAcademic press:RSC Advances (rok: 2024, tom: 14, strony: 18080−18092), Wydawca: Royal Society of ChemistryStatus:PublishedDOI:10.1039/D4RA03141E - link to the publication